Sg Americas Securities, LLC Verastem, Inc. Transaction History

Sg Americas Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$1.06 - $2.1 $25,608 - $50,733	-24,159 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$2.05 - $3.2 $640,801 - $1 Million	-312,586 Reduced 92.83%	24,159 $50,000
Q3 2021 Nov 01, 2021	BUY	$2.54 - $4.07 $147,782 - $236,800	58,182 Added 20.89%	336,745 $1.04 Million
Q2 2021 Aug 12, 2021	BUY	$2.57 - $4.85 $649,235 - $1.23 Million	252,621 Added 973.79%	278,563 $1.13 Million
Q1 2021 May 13, 2021	SELL	$1.9 - $2.82 $25,108 - $37,266	-13,215 Reduced 33.75%	25,942 $64,000
Q4 2020 Feb 04, 2021	BUY	$1.15 - $2.4 $45,030 - $93,976	39,157 New	39,157 $83,000
Q3 2020 Nov 09, 2020	SELL	$1.11 - $1.68 $97,859 - $148,112	-88,162 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$1.69 - $4.2 $148,993 - $370,280	88,162 New	88,162 $152,000
Q1 2019 Apr 29, 2019	SELL	$2.79 - $4.09 $33,480 - $49,080	-12,000 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$3.23 - $7.01 $4,108 - $8,916	-1,272 Reduced 9.58%	12,000 $40,000
Q3 2018 Nov 06, 2018	BUY	$6.86 - $9.97 $91,045 - $132,321	13,272 New	13,272 $96,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.